These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 10953162

  • 1. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC.
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH, Yao S, Kirschenbaum A, Levine AC.
    Cancer Res; 1998 Oct 01; 58(19):4245-9. PubMed ID: 9766645
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M.
    Lab Invest; 1999 Dec 01; 79(12):1469-77. PubMed ID: 10616198
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
    Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC.
    J Biol Chem; 2002 Dec 20; 277(51):50081-6. PubMed ID: 12401798
    [Abstract] [Full Text] [Related]

  • 6. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H, Willard M, Simons J.
    Int J Cancer; 2004 Nov 20; 112(4):585-95. PubMed ID: 15382039
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A.
    Prostate; 2002 Nov 01; 53(3):232-40. PubMed ID: 12386924
    [Abstract] [Full Text] [Related]

  • 8. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM, Harmey JH, O'Grady T, Foley D, Roche-Nagle G, Kay E, Bouchier-Hayes DJ.
    Br J Cancer; 2002 Jul 15; 87(2):231-7. PubMed ID: 12107848
    [Abstract] [Full Text] [Related]

  • 9. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.
    J Am Coll Surg; 2004 Sep 15; 199(3):428-35. PubMed ID: 15325613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ.
    Cancer Biol Ther; 2004 Dec 15; 3(12):1217-24. PubMed ID: 15477758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 15; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs.
    Dandekar DS, Lokeshwar BL.
    Clin Cancer Res; 2004 Dec 01; 10(23):8037-47. PubMed ID: 15585639
    [Abstract] [Full Text] [Related]

  • 19. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G, Caputo R, Damiano V, Melisi D, Bianco R, Fontanini G, Veneziani BM, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2003 Apr 01; 9(4):1566-72. PubMed ID: 12684433
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL, Volpert OV, Iñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M, Redondo JM.
    J Exp Med; 2001 Mar 05; 193(5):607-20. PubMed ID: 11238591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.